Aarti Pharmalabs Share Price Falls 12.44% After Weak Q2 FY26 Results

Vapi, November 10: Aarti Pharmalabs’ share price is witnessing a negative investor demand today after reporting weak financials for the quarter ended September 30. As of 11:50 AM, Aarti Pharmalabs’ share price was down by 12.44%, or 107.60 points, and was trading at ₹757.35. Until now, the Aarti Pharmalabs shares have traded within a range of ₹800 and ₹756. The current traded volume for the Aarti Pharmalabs shares was at 5.26 lakh shares, with the company’s market cap at ₹7,841 crore. The shares have their 52-week high at ₹971 and their 52-week low at ₹234.80.

Aarti Pharmalabs Limited (NSE: AARTIPHARM, BSE: 543748) is an Indian company that manufactures Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and Xanthine derivatives. The company was established in 2019 and is headquartered in Vapi, Gujarat.

Shares Fall After Weak Q2FY26 Financial Results

In Q2 FY26, the company reported revenue from operations of ₹41,833.48 lakh, down 8.7% year-on-year from ₹45,802.58 lakh but up 8.3% quarter-on-quarter from ₹38,619.09 lakh. Total income stood at ₹41,838.51 lakh, declining 9.5% YoY from ₹46,250.87 lakh but a 7.9% QoQ rise. Total expenses were ₹37,905.04 lakh, a decrease of 3.0% YoY from ₹39,074.11 lakh, but 18.3% higher sequentially. Profit before tax dropped by 46.1% YoY to ₹3,869.22 lakh from ₹7,176.76 lakh, and by 40.9% QoQ from ₹6,545.47 lakh. Net profit fell 48.9% YoY to ₹2,792.31 lakh from ₹5,462.25 lakh, also declining 43.6% from ₹4,950.13 lakh in Q1 FY26.

Investor Takeaway for Aarti Pharmalabs

Aarti Pharmalabs has reported weak financials, with almost all key metrics declining in growth. Its revenue is down 8.7%, while its net profit is down 48.9%. The weak financials show that the company is not managing its operations effectively, which has lowered investor sentiment, leading to a share price fall today.

REF: https://nsearchives.nseindia.com/corporate/AARTIPHARMA_09112025152941_Outcome-signed.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations